Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza.

Ziyan Guo, Qiufang Jing, Zhongyu Xu, Dahe Zhang, Wenyun Zheng, Fuzheng Ren

International journal of pharmaceutics 2023 May 10

filter terms:

Cholesterol (CHOL) is essential for developing lipid nanoparticles (LNPs) for gene delivery because it enhances membrane fusion and improves the delivery efficiency of gene cargos. An attractive pDNA carrier, corosolic acid (CA)-modified lipid nanoparticles (CLNPs), was developed by replacing CHOL in LNPs to deliver pDNA at various ratios of nitrogen groups to phosphate groups (N/P). The resultant CLNPs with a higher CHOL/CA ratio exhibited similar mean particle size, zeta potential, and encapsulation efficiency to those of LNPs. In comparison with LNPs, CLNPs (CHOL:CA ratio = 2:1) achieved increased cellular uptake and enhanced transfection efficacy while maintaining low cytotoxicity. In vivo results from chicken experiments demonstrated that CLNPs encapsulating DNA vaccines against avian influenza at a N/P ratio of 3 could elicit similar-level humoral and cellular immune responses compared with those of LNPs at a higher N/P ratio, thereby suggesting the induction of desirable immune effects using less ionizable lipids. Our study provides a reference for further research on the application of CA in LNPs for gene delivery, and the development of novel delivery systems for DNA vaccines against avian influenza. Copyright © 2023 Elsevier B.V. All rights reserved.

Citation

Ziyan Guo, Qiufang Jing, Zhongyu Xu, Dahe Zhang, Wenyun Zheng, Fuzheng Ren. Corosolic acid-modified lipid nanoparticles as delivery carriers for DNA vaccines against avian influenza. International journal of pharmaceutics. 2023 May 10;638:122914